Results 141 to 150 of about 16,198 (182)

Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial. [PDF]

open access: yesBlood Adv
Balke-Want H   +22 more
europepmc   +1 more source

Early Free Light-Chain Suppression as a Prognostic Marker in Relapsed and Refractory Myeloma Patients Treated With BCMA-Directed CAR-T Cells. [PDF]

open access: yesEJHaem
Richardson T   +12 more
europepmc   +1 more source

Author Correction: Consistent FFP2-masking as part of reducing viral respiratory infections on medical wards for allogeneic hematopoietic stem cell transplantation. [PDF]

open access: yesSci Rep
Richardson T   +10 more
europepmc   +1 more source

Correction: Belisario et al. ABCA1/ABCB1 Ratio Determines Chemo- and Immune-Sensitivity in Human Osteosarcoma. <i>Cells</i> 2020, <i>9</i>, 647. [PDF]

open access: yesCells
Belisario DC   +11 more
europepmc   +1 more source

Terahertz antiferromagnetic dynamics induced by ultrafast spin currents. [PDF]

open access: yesSci Adv
René S   +14 more
europepmc   +1 more source

Predicting early intervention outcomes in autism via individual participant data mega-analysis. [PDF]

open access: yesMol Autism
Mandelli V   +17 more
europepmc   +1 more source

Sequential BCMA CAR T-cell therapy in refractory multiple myeloma. [PDF]

open access: yesBlood Adv
Richardson T   +12 more
europepmc   +1 more source

A Brief Observation to Screen Autism in Toddlers and Predict Developmental Trajectory. [PDF]

open access: yesJ Pediatr Clin Pract
Journal F   +6 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy